These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37364692)

  • 1. Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis.
    Cui Y; Zhang W; Yang P; Zhu S; Luo S; Li M
    Free Radic Biol Med; 2023 Sep; 206():33-49. PubMed ID: 37364692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.
    Zhu S; Cui Y; Zhang W; Ji Y; Li L; Luo S; Cui J; Li M
    Drug Des Devel Ther; 2024; 18():2793-2812. PubMed ID: 38979400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.
    Gkouveris I; Hadaya D; Elzakra N; Soundia A; Bezouglaia O; Dry SM; Pirih F; Aghaloo T; Tetradis S
    J Bone Miner Res; 2022 Sep; 37(9):1775-1786. PubMed ID: 35711109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
    Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):871-877. PubMed ID: 33791853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
    Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
    BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
    Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
    Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
    Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
    Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
    Support Care Cancer; 2022 Mar; 30(3):2341-2348. PubMed ID: 34738163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
    Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
    Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction.
    Park KM; Cheong J; Pang NS; Kim KD; Lee JS; Park W
    BMC Oral Health; 2023 Aug; 23(1):561. PubMed ID: 37573298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis.
    Lima-Verde MEQ; de Queiroz Rodrigues MI; Vieira BR; Lima-Verde Neto FTG; Agressott EVH; de Sousa FB; Paschoal AR; de Barros Silva PG; Sousa FB; Mota MRL; Alves APNN
    J Bone Miner Metab; 2023 Nov; 41(6):760-771. PubMed ID: 37673837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.
    Zhao B; Zhao W; Wang Y; Zhao Z; Zhao C; Wang S; Gao C
    PLoS One; 2018; 13(8):e0202269. PubMed ID: 30125322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw.
    Yang G; Collins JM; Rafiee R; Singh S; Langaee T; McDonough CW; Holliday LS; Wang D; Lamba JK; Kim YS; Pelliccioni GA; Vaszilko M; Kosa JP; Balla B; Lakatos PA; Katz J; Moreb J; Gong Y
    J Bone Miner Res; 2021 Feb; 36(2):347-356. PubMed ID: 32967053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
    Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
    BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
    Anitua E; Zalduendo M; Troya M; Orive G
    Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
    Soundia A; Hadaya D; Chau Y; Gkouveris I; Bezouglaia O; Dry S; Pirih F; Aghaloo T; Tetradis S
    Bone; 2021 Jul; 148():115945. PubMed ID: 33836308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw.
    Chen X; Zhu W; Xu R; Shen X; Fu Y; Cheng J; Liu L; Jiang H
    Front Cell Dev Biol; 2021; 9():770899. PubMed ID: 34805177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
    Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.